Beta-blockers, the gold standard drug treatment for heart attacks, is ineffective for many and may increase the risk of death ...

Psychiatrist Dr. Daniel Amen explains how beta blockers work for anxiety by blocking adrenaline effects, as the medication is ...

Sacubitril/valsartan shows evidence of benefit in the first randomized trial evaluating a drug treatment for patients with ...

Beta-blockers are still crucial for some, but new research calls into question the benefit for a large proportion of patients ...

Scientists have demonstrated that a common blood thinner is more effective than aspirin—and just as safe—for patients with ...

A new study says a common drug prescribed after a heart attack does not benefit the vast majority of people who take it.

Emerging evidence suggests a better option already exists. A recent meta-analysis by an international team of cardiologists finds that clopidogrel – which stops blood platelets from clumping – is a ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

Heart disease, one of the leading causes of death worldwide, has long posed challenges in terms of both treatment and prevention. However, with recent advances in pharmaceutical medicine, managing ...

When the heart struggles to pump efficiently, a cascade of events unfolds. Fluid accumulates in the lungs and extremities. Breathing becomes labored. Simple activities like climbing stairs or carrying ...

Results from a large trial suggest baxdrostat could provide a new option for people whose blood pressure remains high despite standard treatment.

For millions of people with heart failure, the latest treatment options — including advanced surgical procedures and innovative devices to assist a failing heart — can be game-changing, especially ...